Medicine and Dentistry
Neoplasm
100%
Pediatrics
90%
Ganglioglioma
67%
Brain Tumor
59%
Malignant Neoplasm
55%
DNA Mismatch Repair
50%
Medulloblastoma
32%
Neurofibromatosis Type I
32%
Toddlers
31%
Overall Survival
24%
Methotrexate
23%
Visual Acuity
21%
Retinoblastoma
21%
Drug Megadose
20%
Infection
20%
Magnetic Resonance Imaging
19%
Surgery
19%
Disease
19%
Pediatrics Patient
18%
Craniospinal Irradiation
17%
Diagnosis
17%
Metastatic Carcinoma
16%
Intensive Care
16%
Atypical Teratoid Rhabdoid Tumor
15%
Pediatric Hematology
15%
Oncology
15%
Cancer Surgery
15%
Ependymoma
15%
Visual Field
14%
Optical Coherence Tomography
14%
Cohort Analysis
14%
Ewing Sarcoma
14%
Scoring System
14%
Sepsis
14%
Cerebrospinal Fluid
14%
COVID-19
14%
Optic Neuropathy
14%
Optic Nerve
13%
microRNA
13%
Cancer Susceptibility
13%
Gene Repair
12%
Event Free Survival
11%
Visual Impairment
11%
Hydrocephalus
11%
Prevalence
10%
Pediatric Cancer
10%
Limb
10%
Deterioration
9%
Gene Mutation
9%
Rosette Formation
9%
Keyphrases
Tumor
63%
Neurofibromatosis Type 1 (NF-1)
49%
Constitutional Mismatch Repair Deficiency (CMMRD)
42%
Medulloblastoma
40%
Brain Tumor
37%
Pediatric
34%
Chemotherapy
33%
Optic Pathway Glioma
32%
Pediatric Low-grade Glioma
32%
Young children
29%
Neurofibromatosis Type I
28%
Methotrexate
23%
Relapsed or Refractory
21%
Ewing Sarcoma
21%
Event-free Survival
21%
Retinoblastoma
21%
Visual Acuity
21%
Working Diagnosis
20%
Pediatric Patients
19%
Molecular Subgroups
18%
High Dose
16%
Craniospinal Irradiation
16%
Mismatch Repair Genes
16%
Pediatric Hematology
16%
Risk Factors
15%
COVID-19
15%
Atypical Teratoid Rhabdoid Tumor (AT/RT)
15%
PMS2
15%
Overall Survival
15%
Treatment Protocol
15%
Medulloblastoma Subgroups
15%
Ophthalmological
15%
BRAF Inhibitor (BRAFi)
15%
Clinical Data
14%
Firefly
14%
Pilot Treatment
14%
Cerebrospinal Fluid
14%
Optical Coherence Tomography
14%
Mismatch Repair
14%
Registry Study
14%
Genome Analysis
14%
Rare Brain Tumours
14%
Oncology Patients
14%
Stem Cell Transplantation
14%
Haemato-oncological Diseases
14%
Intensive Care Admission
14%
Pediatric Intensive Care Unit
14%
Prediction Accuracy
14%
Pediatric Risk of Mortality
14%
Survival Risk
14%